Protagonist Therapeutics
PTGX
PTGX
132 hedge funds and large institutions have $817M invested in Protagonist Therapeutics in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 58 increasing their positions, 34 reducing their positions, and 31 closing their positions.
Holders
132
Holders Change
-6
Holders Change %
-4.35%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-80%
% of All Funds
0.04%
New
26
Increased
58
Reduced
34
Closed
31
Calls
$25.9M
Puts
$15.1M
Net Calls
+$10.7M
Net Calls Change
+$12M
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
JGC
151
J. Goldman & Co
New York
| – | -$897K | -19,986 | Closed |
|
152
Principal Financial Group
Des Moines,
Iowa
| – | -$743K | -16,540 | Closed |
|
|
KAS
153
Kestra Advisory Services
Austin,
Texas
| – | -$626K | -13,939 | Closed |
|
|
AB
154
Amalgamated Bank
New York
| – | -$350K | -7,807 | Closed |
|
|
WG
155
Winton Group
London,
United Kingdom
| – | -$244K | -5,431 | Closed |
|
|
SSA
156
Schonfeld Strategic Advisors
New York
| – | -$224K | -5,000 | Closed |
|
|
GAM
157
Gotham Asset Management
New York
| – | -$215K | -4,793 | Closed |
|
|
EGM
158
Engineers Gate Manager
New York
| – | -$211K | -4,710 | Closed |
|
|
FC
159
FORA Capital
Miami,
Florida
| – | -$123K | -2,731 | Closed |
|
|
HFM
160
Hartford Financial Management
Hartford,
Connecticut
| – | -$13K | -300 | Closed |
|